Technology | July 25, 2011

RFID Tracking and Verification System Featured at AAPM

July 25, 2011 – Civco Medical Solutions is showcasing its RFSuite radio frequency identification (RFID) tracking and verification system at the annual meeting of the American Association of Physicists in Medicine (AAPM). Civco also is hosting an RFSuite Symposium, from 12:30 – 2 p.m Monday, Aug. 1, in the Mackenzie Ballroom at the Fairmont Waterfront, Vancouver. The event will include lunch. Pre-registration is required, and spots are still available.

The symposium will include several speakers experienced with RFID technology, including Todd Pawlicki, Ph.D., director of medical physics and clinical operations at Moores Cancer Center in San Diego, Calif., and Alfredo Siochi, Ph.D., assistant professor and director of medical physics education in the department of radiation oncology at the University of Iowa Hospital and Clinics in Iowa City, Iowa. Moores Cancer Center has been using Civco’s RFSuite for nearly a year.

Civco will also sponsor an RFID and workflow consortium at AAPM to learn more about the clinical benefits of RF technology.  

The RFSuite system uses RFID technology to track patients, staff and equipment and to provide accessory and patient identity verification for treatment. “The use of RFID technology provides real-time information about resource availability and pending tasks,” said Siochi. “Schedule optimization could match resources to tasks and in our RFID simulation study, this reduced patient wait times by 30 minutes.”

The RFSuite software, RFTrak, provides a snapshot of where people and items are located in a facility in real time, improving workflow and reducing patient wait time. Civco’s RFSeries line provides a broad array of RFID enabled products.

“RFID technology is uniquely positioned to have a major impact in radiation oncology,” said Pawlicki. “In addition to equipment and resource tracking, RFID will provide the real-time process data that can be used as the basis for comprehensive performance and safety programs. We look forward to working with Civco in developing its RFID technology as a key component of our data-driven improvement approaches, such as Lean or Six Sigma.”

For more information: www.Civco.com

Related Content

Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center
News | Stereotactic Body Radiation Therapy (SBRT) | February 27, 2020
February 27, 2020 — Accuray Incorporated announced that Mercy
An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure

Arizona State University researchers (in collaboration with Banner MD Anderson Cancer Center) have discovered a biocompatible cost-effective hydrogel that can be used to monitor therapeutic doses of ionizing radiation by becoming more pink with increasing radiation exposure. This picture shows a circle of hydrogel that was irradiated on the left half, which is slightly pink; whereas the right half of the gel is not irradiated and remains colorless.

News | Radiation Therapy | February 18, 2020
February 18, 2020 — More than half of all cancer patients undergo radiation therapy and the dose is critical.
Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
SIR President Laura Findeiss, M.D., FSIR

SIR President Laura Findeiss, M.D., FSIR

News | Interventional Radiology | February 09, 2020
February 9, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26 percent of patients undergoing pulmonary resection for non-small-cell lung cancer (NSCLC)

A Purdue discovery being developed by On Target Laboratories Inc., illuminates lung cancer cells on a patient during surgery. The “fluorescent markers” help medical professionals identify and remove cancer cells during surgery and is shown to improve outcomes. The technology is beginning Phase 3 clinical trials. (Photo provided by On Target)

News | Molecular Imaging | February 06, 2020
February 6, 2020 — ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.